INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled powder shows promise for Lung-Related high blood pressure
Disease control OngoingThis study tests the safety of an inhaled dry powder drug called LIQ861 (treprostinil) in 80 adults with pulmonary hypertension (high blood pressure in the lungs) linked to lung disease. Participants receive the drug through an inhaler, and researchers monitor for side effects. T…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated May 17, 2026 00:41 UTC
-
New radiation approach targets lung cancer in patients with scarred lungs
Disease control OngoingThis study tests a highly targeted form of radiation therapy (SABR) in people with early-stage non-small cell lung cancer who also have interstitial lung disease, a condition that makes the lungs stiff and scarred. The goal is to see if this precise radiation can control the canc…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated May 17, 2026 00:39 UTC
-
Inhaled drug shows promise for lung scarring in Long-Term safety trial
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of an inhaled medication called treprostinil for people with lung scarring conditions like idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). About 1,850 adults who have already taken part in a related study will …
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New drug shows promise for scleroderma lung disease in early trial
Disease control OngoingThis study tests a new drug, tulisokibart, in 154 adults with systemic sclerosis (scleroderma) that has caused lung scarring (interstitial lung disease). The goal is to see if the drug can slow lung damage and improve breathing compared to a placebo. Participants must have had sc…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New inhaled therapy shows promise for Hard-to-Treat lung condition
Disease control OngoingThis study tests an inhaled medicine called mosliciguat in 135 people who have high blood pressure in their lungs due to scarring lung disease. The goal is to see if it improves blood flow and walking ability over 16 weeks. Participants are randomly assigned to receive the drug o…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New CT tool aims to sharpen diagnosis of scarred lungs
Diagnosis OngoingThis study aims to create and test a tool that uses chest CT scans to help doctors more accurately diagnose different types of pulmonary fibrosis, a condition where lung tissue becomes scarred. Researchers will analyze CT scans from 400 adults to identify patterns linked to speci…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Columbia University • Aim: Diagnosis
Last updated May 17, 2026 00:28 UTC
-
New screening method aims to catch hidden Heart-Lung condition early
Diagnosis OngoingThis study tests whether special screening methods can find pulmonary hypertension (high blood pressure in the lungs) earlier in people with interstitial lung disease. About 300 adults with various types of ILD will be screened using heart catheterization to confirm the condition…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: United Therapeutics • Aim: Diagnosis
Last updated May 07, 2026 18:41 UTC
-
Firefighters get new screening for hidden lung risks
Knowledge-focused TerminatedThis study aimed to give firefighters low-dose chest CT scans to check for lung cancer and other lung diseases caused by smoke and chemical exposure. It focused on firefighters aged 35 and older who never smoked or quit long ago. The study was withdrawn before enrolling anyone, s…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
9/11 Workers' lungs under the microscope: new study seeks answers
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at chest CT scans and breathing tests from over 2,000 World Trade Center workers and volunteers to better understand lung diseases like chronic airway disease, scarring, and cancer. Researchers want to see how these findings relate to symptoms and exposure to dus…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC